Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Germline Pathogenic Mutations in Patients With Pancreatic Adenocarcinoma

NCT03982446 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.

NCT NCT03982446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03982446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Germline Pathogenic Mutations in Patients With Pancreatic Adenocarcinoma
Lead sponsor
Hellenic Cooperative Oncology Group
Phase
Observational
Overall status
Completed
Start date
March 1, 2016
Completion date
January 3, 2020
Enrollment
549 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

germline mutation abnormality, hereditary cancer, pancreatic cancer, predisposition, genetic